Variant report
Variant | nsv877044 |
---|---|
Chromosome Location | chr3:82214617-82266033 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CADM2-6 | chr3:82234526-82234604 | NONHSAT090628 |
2 | lnc-CADM2-6 | chr3:82234503-82234604 | ENSG00000239440 |
3 | lnc-CADM2-6 | chr3:82251480-82251605 | ENSG00000239440 |
4 | lnc-CADM2-6 | chr3:82234503-82234604 | ENSG00000239440 |
5 | lnc-CADM2-6 | chr3:82251480-82251605 | ENSG00000239440 |
6 | lnc-CADM2-6 | chr3:82251480-82251605 | NONHSAT090628 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ERO1LB | miRNA target sites |
TNFAIP3 | miRNA target sites |
YWHAH | miRNA target sites |
ZFP91 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1534322 | chr3:82214617-82214618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540377032 | chr3:82214622-82214623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530541383 | chr3:82214662-82214663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550646513 | chr3:82214741-82214742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141782941 | chr3:82226406-82226407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188098763 | chr3:82226423-82226424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563451810 | chr3:82226474-82226475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577244858 | chr3:82226484-82226485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545793408 | chr3:82226487-82226488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7634781 | chr3:82226496-82226497 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs115815904 | chr3:82226508-82226509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs35468238 | chr3:82226543-82226544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79353498 | chr3:82226604-82226605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147091553 | chr3:82226608-82226609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530250415 | chr3:82226622-82226623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550412739 | chr3:82226628-82226629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111968316 | chr3:82226630-82226631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs4398457 | chr3:82226631-82226632 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs111308969 | chr3:82226643-82226644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377285963 | chr3:82226705-82226706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538996896 | chr3:82226713-82226714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191937119 | chr3:82226895-82226896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532067369 | chr3:82226902-82226903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184361184 | chr3:82226950-82226951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35564113 | chr3:82226997-82226998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554788217 | chr3:82227020-82227021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371343124 | chr3:82227094-82227095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564284222 | chr3:82227147-82227148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574540958 | chr3:82227265-82227266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536838617 | chr3:82227303-82227304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557220625 | chr3:82227304-82227305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533368534 | chr3:82227340-82227341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142640599 | chr3:82227344-82227345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541279774 | chr3:82227489-82227490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34462127 | chr3:82227523-82227524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549956641 | chr3:82227554-82227555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9848134 | chr3:82227635-82227636 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs541878404 | chr3:82227668-82227669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552070375 | chr3:82227673-82227674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189133615 | chr3:82227716-82227717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543655260 | chr3:82227728-82227729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113599006 | chr3:82227734-82227735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563583016 | chr3:82227797-82227798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73844129 | chr3:82227833-82227834 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs181855583 | chr3:82227840-82227841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529382222 | chr3:82227853-82227854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73135737 | chr3:82227874-82227875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565559833 | chr3:82227879-82227880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148204170 | chr3:82227883-82227884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185714528 | chr3:82227899-82227900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Autism | 20808228 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:82213800-82214800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr3:82226400-82228000 | Enhancers | Ovary | ovary |
3 | chr3:82227800-82228000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr3:82228600-82228800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr3:82230800-82232000 | Enhancers | Dnd41 | blood |
6 | chr3:82232800-82233400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr3:82233200-82233400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr3:82233600-82238200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr3:82235000-82235600 | Enhancers | Ovary | ovary |
10 | chr3:82235200-82235400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr3:82238200-82239000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr3:82243800-82244600 | Enhancers | HUVEC | blood vessel |
13 | chr3:82249800-82252400 | Enhancers | Fetal Heart | heart |
14 | chr3:82252400-82257400 | Weak transcription | Fetal Heart | heart |
15 | chr3:82254200-82254800 | Enhancers | Primary B cells from peripheral blood | blood |
16 | chr3:82254200-82258000 | Enhancers | Primary B cells from cord blood | blood |
17 | chr3:82254800-82255800 | Weak transcription | Primary B cells from peripheral blood | blood |
18 | chr3:82255800-82257400 | Enhancers | Primary B cells from peripheral blood | blood |
19 | chr3:82257400-82258000 | Enhancers | Fetal Heart | heart |
20 | chr3:82258000-82262800 | Weak transcription | Fetal Heart | heart |
21 | chr3:82258800-82259000 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr3:82259000-82260600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
23 | chr3:82262800-82263800 | Enhancers | Fetal Heart | heart |